Forte Biosciences (FBRX) Reports Q2 Loss of $0.42/sh
Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.42), versus ($0.21) reported last year.
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.42), versus ($0.21) reported last year.
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.